Longeveron (LGVN) Announces FDA Approves its Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Longeveron (LGVN) Announces FDA Approves its Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition
LOGICVISION (NASDAQ: LGVN) Delayed: 0.83 +0.03 (3.75%)
Previous Close $0.80    52 Week High $1.62 
Open $0.80    52 Week Low $0.35 
Day High $0.85    P/E N/A 
Day Low $0.80    EPS $-0.17 
Volume 38,473